title: Random effects meta-analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation.
abstract: A random effects meta-analysis combines the results of several independent studies to summarise the evidence about a particular measure of interest, such as a treatment effect. The approach allows for unexplained between-study heterogeneity in the true treatment effect by incorporating random study effects about the overall mean. The variance of the mean effect estimate is conventionally calculated by assuming that the between study variance is known; however, it has been demonstrated that this approach may be inappropriate, especially when there are few studies. Alternative methods that aim to account for this uncertainty, such as Hartung-Knapp, Sidik-Jonkman and Kenward-Roger, have been proposed and shown to improve upon the conventional approach in some situations. In this paper, we use a simulation study to examine the performance of several of these methods in terms of the coverage of the 95% confidence and prediction intervals derived from a random effects meta-analysis estimated using restricted maximum likelihood. We show that, in terms of the confidence intervals, the Hartung-Knapp correction performs well across a wide-range of scenarios and outperforms other methods when heterogeneity was large and/or study sizes were similar. However, the coverage of the Hartung-Knapp method is slightly too low when the heterogeneity is low (I2< 30%) and the study sizes are quite varied. In terms of prediction intervals, the conventional approach is only valid when heterogeneity is large (I2> 30%) and study sizes are similar. In other situations, especially when heterogeneity is small and the study sizes are quite varied, the coverage is far too low and could not be consistently improved by either increasing the number of studies, altering the degrees of freedom or using variance inflation methods. Therefore, researchers should be cautious in deriving 95% prediction intervals following a frequentist random-effects meta-analysis until a more reliable solution is identified. © 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd.
authors.affiliation: National Perinatal Epidemiology Unit, Oxford, U.K.|University of Birmingham, Birmingham, U.K.
authors.forename: Christopher
authors.initials: C
authors.lastname: Partlett
authors.affiliation: Research Institute for Primary Care and Health Sciences, Keele University, Keele, U.K.
authors.forename: Richard D
authors.initials: RD
authors.lastname: Riley
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D056808:Biostatistics; D001794:Blood Pressure / Q000187:drug effects; D003198:Computer Simulation; D016001:Confidence Intervals; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D016013:Likelihood Functions; D015201:Meta-Analysis as Topic; D015233:Models, Statistical; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018401:Sample Size; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents
keywords: REML; coverage; meta-analysis; random effects; simulation